EdgarLookup

GENESCO INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that GENESCO INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.5%
Profit Margin
Net income ÷ revenue
1%
Return on Assets
Net income ÷ assets
1.46x
Debt-to-Equity
Total liabilities ÷ equity
+13.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2012 Feb 2, 2013 $2.61B Apr 3, 2013
FY2012 Jan 28, 2012 $2.29B Apr 3, 2013
FY2012 Jan 29, 2011 $1.79B Apr 3, 2013
FY2011 Jan 30, 2010 $1.57B Apr 26, 2012

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $2.44B Mar 25, 2026
FY2026 Feb 1, 2025 $2.33B Mar 25, 2026
FY2026 Feb 3, 2024 $2.32B Mar 25, 2026
FY2025 Jan 28, 2023 $2.38B Mar 26, 2025
FY2024 Jan 29, 2022 $2.42B Mar 27, 2024
FY2023 Jan 30, 2021 $1.79B Mar 22, 2023
FY2020 Feb 1, 2020 $677.58M Apr 1, 2020
FY2020 Nov 2, 2019 $537.26M Apr 1, 2020
FY2020 Aug 3, 2019 $486.57M Apr 1, 2020
FY2020 May 4, 2019 $495.65M Apr 1, 2020

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $1.13B Mar 25, 2026
FY2026 Feb 1, 2025 $1.10B Mar 25, 2026
FY2026 Feb 3, 2024 $1.10B Mar 25, 2026
FY2025 Jan 28, 2023 $1.14B Mar 26, 2025
FY2024 Jan 29, 2022 $1.18B Mar 27, 2024
FY2023 Jan 30, 2021 $804.47M Mar 22, 2023
FY2020 Feb 1, 2020 $317.47M Apr 1, 2020
FY2020 Nov 2, 2019 $264.20M Apr 1, 2020
FY2020 Aug 3, 2019 $236.53M Apr 1, 2020
FY2020 May 4, 2019 $244.91M Apr 1, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $13.27M Mar 25, 2026
FY2026 Feb 1, 2025 ($18.89M) Mar 25, 2026
FY2026 Feb 3, 2024 ($16.83M) Mar 25, 2026
FY2025 Jan 28, 2023 $71.92M Mar 26, 2025
FY2024 Jan 29, 2022 $114.85M Mar 27, 2024
FY2023 Jan 30, 2021 ($56.43M) Mar 22, 2023
FY2022 Jan 29, 2021 ($56.43M) Mar 23, 2022
FY2020 Feb 1, 2020 $35.56M Apr 1, 2020
FY2022 Jan 29, 2020 $61.38M Mar 23, 2022
FY2020 Nov 2, 2019 $18.90M Apr 1, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $17.31M Mar 25, 2026
FY2026 Feb 1, 2025 $13.93M Mar 25, 2026
FY2026 Feb 3, 2024 ($13.46M) Mar 25, 2026
FY2025 Jan 28, 2023 $93.24M Mar 26, 2025
FY2024 Jan 29, 2022 $155.57M Mar 27, 2024
FY2023 Jan 30, 2021 ($107.25M) Mar 22, 2023
FY2022 Feb 1, 2020 $83.32M Mar 23, 2022
FY2021 Feb 2, 2019 $81.82M Mar 31, 2021
FY2020 Feb 3, 2018 $74.37M Apr 1, 2020
FY2018 Jan 28, 2017 $107.79M Apr 3, 2019

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $1.10B Mar 25, 2026
FY2026 Feb 1, 2025 $1.08B Mar 25, 2026
FY2026 Feb 3, 2024 $1.08B Mar 25, 2026
FY2025 Jan 28, 2023 $1.04B Mar 26, 2025
FY2024 Jan 29, 2022 $1.03B Mar 27, 2024
FY2023 Jan 30, 2021 $813.78M Mar 22, 2023
FY2022 Feb 1, 2020 $966.42M Mar 23, 2022
FY2021 Feb 2, 2019 $962.08M Mar 31, 2021
FY2020 Feb 3, 2018 $929.24M Apr 1, 2020
FY2018 Jan 28, 2017 $876.16M Apr 3, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $145.76M Mar 25, 2026
FY2026 Feb 1, 2025 $87.89M Mar 25, 2026
FY2026 Feb 3, 2024 $94.80M Mar 25, 2026
FY2025 Jan 28, 2023 ($164.88M) Mar 26, 2025
FY2024 Jan 29, 2022 $239.87M Mar 27, 2024
FY2023 Jan 30, 2021 $157.74M Mar 22, 2023
FY2022 Feb 1, 2020 $117.17M Mar 23, 2022
FY2021 Feb 2, 2019 $237.14M Mar 31, 2021
FY2020 Feb 3, 2018 $164.59M Apr 1, 2020
FY2018 Jan 28, 2017 $165.25M Apr 3, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $62.05M Mar 25, 2026
FY2026 Feb 1, 2025 $41.13M Mar 25, 2026
FY2026 Feb 3, 2024 $60.30M Mar 25, 2026
FY2025 Jan 28, 2023 $59.93M Mar 26, 2025
FY2024 Jan 29, 2022 $53.91M Mar 27, 2024
FY2023 Jan 30, 2021 $24.13M Mar 22, 2023
FY2022 Feb 1, 2020 $29.77M Mar 23, 2022
FY2021 Feb 2, 2019 $57.23M Mar 31, 2021
FY2020 Feb 3, 2018 $127.85M Apr 1, 2020
FY2018 Jan 28, 2017 $93.97M Apr 3, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $1.39B Mar 25, 2026
FY2026 Feb 1, 2025 $1.34B Mar 25, 2026
FY2026 Feb 3, 2024 $1.33B Mar 25, 2026
FY2025 Jan 28, 2023 $1.46B Mar 26, 2025
FY2024 Jan 29, 2022 $1.56B Mar 27, 2024
FY2023 Jan 30, 2021 $1.59B Mar 22, 2023
FY2022 Feb 1, 2020 $1.68B Mar 23, 2022
FY2021 Feb 2, 2019 $1.18B Mar 31, 2021
FY2020 Feb 3, 2018 $1.32B Apr 1, 2020
FY2017 Jan 28, 2017 $1.44B Apr 4, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $825.93M Mar 25, 2026
FY2026 Feb 1, 2025 $788.57M Mar 25, 2026
FY2025 Feb 3, 2024 $758.69M Mar 26, 2025
FY2024 Jan 28, 2023 $849.46M Mar 27, 2024
FY2023 Jan 29, 2022 $959.63M Mar 22, 2023
FY2022 Jan 30, 2021 $1.02B Mar 23, 2022
FY2021 Feb 1, 2020 $1.06B Mar 31, 2021
FY2020 Feb 2, 2019 $443.53M Apr 1, 2020
FY2018 Feb 3, 2018 $484.65M Apr 3, 2019
FY2017 Jan 28, 2017 $518.48M Apr 4, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $567.04M Mar 25, 2026
FY2026 Feb 1, 2025 $546.97M Mar 25, 2026
FY2026 Feb 3, 2024 $571.20M Mar 25, 2026
FY2026 Jan 28, 2023 $606.97M Mar 25, 2026
FY2025 Jan 29, 2022 $602.47M Mar 26, 2025
FY2024 Jan 30, 2021 $566.76M Mar 27, 2024
FY2023 Feb 1, 2020 $619.34M Mar 22, 2023
FY2022 Feb 2, 2019 $737.55M Mar 23, 2022
FY2021 Feb 3, 2018 $830.70M Mar 31, 2021
FY2017 Jan 28, 2017 $921.05M Apr 4, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $9.46M Mar 25, 2026
FY2026 Feb 1, 2025 $8.86M Mar 25, 2026
FY2025 Feb 3, 2024 $9.57M Mar 26, 2025
FY2024 Jan 28, 2023 $38.12M Mar 27, 2024
FY2023 Jan 29, 2022 $38.56M Mar 22, 2023
FY2022 Jan 30, 2021 $38.55M Mar 23, 2022
FY2021 Feb 1, 2020 $122.18M Mar 31, 2021
FY2020 Feb 2, 2019 $93.08M Apr 1, 2020
FY2018 Feb 3, 2018 $100.31M Apr 3, 2019
FY2017 Jan 28, 2017 $271.22M Apr 4, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $265.79M Mar 25, 2026
FY2026 Feb 1, 2025 $265.89M Mar 25, 2026
FY2025 Feb 3, 2024 $296.77M Mar 26, 2025
FY2024 Jan 28, 2023 $346.87M Mar 27, 2024
FY2023 Jan 29, 2022 $350.21M Mar 22, 2023
FY2022 Jan 30, 2021 $320.92M Mar 23, 2022
FY2021 Feb 1, 2020 $378.57M Mar 31, 2021
FY2020 Feb 2, 2019 $508.56M Apr 1, 2020
FY2018 Feb 4, 2018 $608.32M Apr 3, 2019
FY2018 Feb 3, 2018 $603.90M Apr 3, 2019

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $105.41M Mar 25, 2026
FY2026 Feb 1, 2025 $34.01M Mar 25, 2026
FY2025 Feb 3, 2024 $35.16M Mar 26, 2025
FY2022 Jan 29, 2022 $320.53M Mar 23, 2022
FY2022 Jan 30, 2021 $215.09M Mar 23, 2022
FY2021 Feb 1, 2020 $81.42M Mar 31, 2021
FY2020 Feb 2, 2019 $167.36M Apr 1, 2020
FY2018 Feb 3, 2018 $39.94M Apr 3, 2019
FY2017 Jan 28, 2017 $48.30M Apr 4, 2018
FY2017 Jan 30, 2016 $133.29M Apr 4, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2023 Jan 28, 2023 $44.86M Mar 22, 2023
FY2023 Jan 29, 2022 $15.68M Mar 22, 2023
FY2022 Jan 30, 2021 $32.99M Mar 23, 2022
FY2021 Feb 1, 2020 $14.39M Mar 31, 2021
FY2020 Feb 2, 2019 $65.74M Apr 1, 2020
FY2018 Feb 3, 2018 $88.39M Apr 3, 2019
FY2017 Jan 28, 2017 $82.91M Apr 4, 2018
FY2017 Jan 30, 2016 $111.77M Mar 29, 2017
FY2016 Jan 31, 2015 $29.16M Mar 30, 2016
FY2014 Feb 1, 2014 $33.73M Apr 1, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 1 Mar 25, 2026
FY2026 Feb 1, 2025 (1) Mar 25, 2026
FY2026 Feb 3, 2024 (1) Mar 25, 2026
FY2025 Jan 28, 2023 5 Mar 26, 2025
FY2024 Jan 29, 2022 8 Mar 27, 2024
FY2023 Jan 30, 2021 (3) Mar 22, 2023
FY2022 Feb 1, 2020 3 Mar 23, 2022
FY2021 Feb 2, 2019 (2) Mar 31, 2021
FY2020 Feb 3, 2018 (5) Apr 1, 2020
FY2018 Jan 28, 2017 4 Apr 3, 2019

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 1 Mar 25, 2026
FY2026 Feb 1, 2025 (1) Mar 25, 2026
FY2026 Feb 3, 2024 (1) Mar 25, 2026
FY2025 Jan 28, 2023 5 Mar 26, 2025
FY2024 Jan 29, 2022 7 Mar 27, 2024
FY2023 Jan 30, 2021 (3) Mar 22, 2023
FY2020 Feb 1, 2020 2 Apr 1, 2020
FY2020 Nov 2, 2019 1 Apr 1, 2020
FY2020 Aug 3, 2019 0 Apr 1, 2020
FY2020 May 4, 2019 0 Apr 1, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2020 Feb 1, 2020 14.70M Apr 1, 2020
FY2020 Feb 2, 2019 19.10M Apr 1, 2020
FY2018 Feb 3, 2018 19.90M Apr 3, 2019
FY2017 Jan 28, 2017 19.87M Apr 4, 2018
FY2017 Jan 30, 2016 21.83M Mar 29, 2017
FY2016 Jan 31, 2015 24.03M Mar 30, 2016
FY2014 Feb 1, 2014 23.92M Apr 1, 2015
FY2014 Feb 2, 2013 24.00M Apr 3, 2014
FY2013 Jan 28, 2012 24.27M Sep 24, 2013
FY2011 Jan 29, 2011 23.67M Apr 26, 2012